Market Shockwaves: Vaccine Manufacturer Stocks Plummet as Trump Appoints RFK Jr. to Head HHS

In a surprising political move that has sent ripples through the pharmaceutical industry, former President Donald Trump has appointed Robert F. Kennedy Jr. as the new head of the Department of Health and Human Services (HHS). This unexpected selection has led to an immediate downturn in the stock prices of major vaccine manufacturers, reflecting investor concerns over Kennedy's controversial stance on vaccines.

Continue reading